Rapid High Performance Liquid Chromatographic Determination of Risperidone in Human Plasma

authors:

avatar Seyed Mohsen Foroutan 1 , * , avatar Afshin Zarghi 2 , avatar Alireza Shafaati 2 , avatar Arash Khoddam 3

Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
Department of Pharmaceutical Chemistry, School of Pharmacy, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
Noor Research and Educational Institute, Tehran, Iran

how to cite: Foroutan S M, Zarghi A, Shafaati A, Khoddam A. Rapid High Performance Liquid Chromatographic Determination of Risperidone in Human Plasma. Iran J Pharm Res. 2006;5(1):e128260. https://doi.org/10.22037/ijpr.2010.650.

Abstract

A simple, rapid and sensitive high-performance liquid chromatographic (HPLC) method for the determination of risperidone in human plasma was developed. An HPLC system based on a Nucleosil C8 column (150×4 mm) and a UV detector (λ= 280 nm) were used. A mixture of sodium dihydrogen phosphate buffer-acetonitrile (55:45, v/v) adjusted to pH 6.0 at a flow rate of 1.5 ml min-1 was used as mobile phase. The proteins were precipitated with an acetonitrile solution containing diltiazem as internal standard and the average recovery was 93.9±3.4%. The detection limit for risperidone in plasma was 0.5 ngml-1. The calibration curve was linear over the concentration range 2-50 ngml-1. The inter-day and intra-day assay coefficients of variation were found to be less than 5%. The present validated method was successfully used for pharmacokinetic studies of risperidone in human subjects.